Catheter Ablation of Well Tolerated Ventricular Tachycardia in Patients With Structural Heart Disease and Without Automatic Defibrillator Implantation: Long Term Follow-up

• Published in: Current problems in cardiology Vol. 47; no. 12; p. 101349
• Main Authors: Cardelli, Laura Sofia, Barbato, Gaetano, Carinci, Valeria, Pergolini, Francesco, Leci, Enri, Casella, Gianni
• Format: Journal Article
• Language: English
• Published: Elsevier Inc 01.12.2022
• Subjects: LVEF; HR; ICD; IQR; LGE; SHD; VF; 3D; AADs; RF; SCD; EP study; Bpm; SMVT; VT
• ISSN: 0146-2806; 1535-6280
• DOI: 10.1016/j.cpcardiol.2022.101349

The occurrence of a sustained monomorphic ventricular tachycardias (SMVT) in patients with underlying structural heart disease (SHD) is considered related to poor prognosis. The purpose of our work was to evaluate if these patients could benefit from radiofrequency (RF) ablation, and the defibrillator (ICD) implantation could be deferred during follow-up. We reviewed consecutive patients with well-tolerated SMVT, SHD and left ventricular ejection fraction over 30%. These patients were treated by RF ablation and were discharged without ICD. The primary outcome was a composite of all-cause death and recurrence of SMVT; the secondary outcome was death from all causes. Sixty-two patients were selected. After a median follow-up of 38.8 months, the primary outcome occurred in 24 (38.7%) and the secondary in 11 (17.7%) patients. The annual mortality rate was 4.3% and no patient died from sudden death. RF ablation as a first-choice therapy seems to represent an effective and beneficial therapeutic approach.